Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-02-20
1990-04-17
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3150
Patent
active
049180720
ABSTRACT:
A combination of a phenylacetonitrile and a pyridazinone derivative can be used for the treatment of thromboembolic disorders.
REFERENCES:
patent: 3261859 (1966-07-01), Dengel
patent: 4258185 (1981-03-01), Nakao et al.
patent: 4438131 (1984-03-01), Ehrmann et al.
patent: 4474785 (1984-10-01), Rossy et al.
Rossy et al., Chem. Abst. 101(25):230558w (1984).
Liste Pharmindex III/84, pp. 648; 1024-1025.
BASF - Aktiengesellschaft
Robinson Douglas W.
LandOfFree
Platelet aggregation inhibiting composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregation inhibiting composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibiting composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1052900